- Home
- AKRO vs WRBY Comparison
AKRO vs WRBY Comparison
Compare AKRO & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKRO | WRBY |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 2.1B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AKRO | WRBY |
|---|---|---|
| Price | $54.65 | $27.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $73.56 | $25.13 |
| AVG Volume (30 Days) | 2.4M | ★ 5.5M |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $850,580,000.00 |
| Revenue This Year | N/A | $15.47 |
| Revenue Next Year | N/A | $12.84 |
| P/E Ratio | ★ N/A | $4,668.50 |
| Revenue Growth | N/A | ★ 14.55 |
| 52 Week Low | $21.34 | $13.63 |
| 52 Week High | $58.40 | $31.00 |
Technical Indicators
Market Signals| Indicator | AKRO | WRBY |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 69.93 |
| Support Level | $54.30 | $17.83 |
| Resistance Level | $54.70 | $31.00 |
| Average True Range (ATR) | 0.17 | 1.85 |
| MACD | -0.10 | 1.35 |
| Stochastic Oscillator | 71.07 | 75.21 |
Price Performance
Historical ComparisonAbout AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.